Open-Label Extension of EryDex Study IEDAT-04-2022

Clinical trial NCT06664853 · TERMINATED

Trial details

NCT number: NCT06664853
Sponsor: Quince Therapeutics S.p.A.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Ataxia Telangiectasia

Start date: 2024-12-11
Primary completion: 2026-01-30
Enrollment: 101

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.